| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |